Open access · CC-BY
via OpenAlex
Salient Genetic and Proteomic Pathways in Glaucoma
World Journal of Ophthalmology & Vision Research · 2020
Abstract
Glaucoma, the second leading cause of blindness worldwide is a neurodegenerative disease, with or without elevated ocular pressure, exhibiting several different phenotypic presentations, which result in progressive visual field loss after compromise of retinal ganglion cells and their axons to the optic nerve and brain. Predominant clinical glaucoma types are primary open angle, POAG, angle closure, and congenital; secondary glaucomas are: psuedoexfoliaiton, pigmentary, neovascular, traumatic, iridoendothelial, and uveitic glaucoma. In each of these types of glaucoma, genetic, epigenetic, proteomic, environmental, and mechanical forces may converge as well to cause or advance the disease. Alternatively, but not necessarily in an independent fashion, stress related pathways of oxidative stress, inflammation, infection, trauma, immune reaction, neuro-degeneration and mutant genomic products can produce deleterious misfolded proteins, antibodies, and aggregate deposits in the trabecular meshwork, TM, raise the intraocular pressure and result in optic nerve damage and loss of vision. Examining the interplay of these stress pathways with genetic, epigenetic, proteomic, environmental and mechanical forces to gain some understanding of molecular causes of glaucoma is the goal of this paper.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.33552/wjovr.2020.03.000565
- Canonical
- link ↗
- Fetched
- 2026-10-14 MST
Cite this
APA
Eichenbaum, J.W. (2020). Salient Genetic and Proteomic Pathways in Glaucoma. <em>World Journal of Ophthalmology & Vision Research</em>. https://doi.org/10.33552/wjovr.2020.03.000565
Vancouver
Eichenbaum JW. Salient Genetic and Proteomic Pathways in Glaucoma. World Journal of Ophthalmology & Vision Research. 2020. doi:10.33552/wjovr.2020.03.000565.
BibTeX
@article{joseph2020Salien,
title = {Salient Genetic and Proteomic Pathways in Glaucoma},
author = {Joseph W. Eichenbaum},
journal = {World Journal of Ophthalmology & Vision Research},
year = {2020},
doi = {10.33552/wjovr.2020.03.000565},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
The Journal of Headache and Pain 2026
Open access · CC-BY
Whole blood DNA methylation signature of epigenetic aging in medication overuse headache
The Journals of Gerontology Series A 2021
Open access · CC-BY
The Association Between Epigenetic Clocks and Physical Functioning in Older Women: A 3-Year Follow-up
Journal of Affective Disorders 2025
Citation only
Sleep disorders and aging: Mendelian randomization analysis of epigenetic and frailty markers
The Thoracic and Cardiovascular Surgeon 2018
Citation only
Epigenetic Alterations in Cardiac Sarcoma
Trials 2022
Open access · CC-BY
Nicotinamide riboside as a neuroprotective therapy for glaucoma: study protocol for a randomized, double-blind, placebo-control trial
PLoS ONE 2011
Open access · CC-BY